ClinicalTrials.gov
public full text
Public Domain
An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia
A project has been developed in Edmonton, Alberta, Canada to enable male patients with choroideremia to access a clinical trial that replaces the defective gene with a normal copy. This experiment is designed to show that the transfer of a normal copy of the gene to the eye is not only safe but may improve the sight of patients. Only Canadian subjects who meet criteria will be recruited.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- THOR - Tübingen Choroideremia Gene Therapy Trial#846391
- A Safety Study of Retinal Gene Therapy for Choroideremia With Administration of BIIB111#825416
- Genetic and Risk Factors in Exfoliation Glaucoma Patients#849279
- Current Status of Clinical Trials Design and Outcomes in Retinal Gene Therapy#360971
- Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy#1153663
Record · ID 918115
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive